These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8718569)

  • 41. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Yu HH; Chen PC; Yang YH; Wang LC; Lee JH; Lin YT; Chiang BL
    Atherosclerosis; 2015 Nov; 243(1):11-8. PubMed ID: 26342937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of apolipoprotein E gene polymorphism with end-stage renal disease and hyperlipidemia in patients on long-term hemodialysis.
    Lahrach H; Essiarab F; Timinouni M; Hatim B; El Khayat S; Er-Rachdi L; Jarir J; Kettani A; Ghalim N; Taki H; Lebrazi H; Ramdani B; Saïle R
    Ren Fail; 2014 Nov; 36(10):1504-9. PubMed ID: 25155022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Summary of the national guidelines for the diagnosis and management of lipid disorders in Taiwan. The experts panel.
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jan; 55(1):1-14. PubMed ID: 7712390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients.
    Saltissi D; Morgan C; Knight B; Chang W; Rigby R; Westhuyzen J
    Am J Kidney Dis; 2001 Jun; 37(6):1209-15. PubMed ID: 11382690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of diet on lipid abnormalities in human renal disease.
    D'Amico G; Gentile MG
    Am J Kidney Dis; 1993 Jul; 22(1):151-7. PubMed ID: 8322778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
    Khurana M; Silverstein DM
    Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metabolic syndrome and hyperlipidemia in HIV-positive patients].
    Behrens GM
    Herz; 2005 Sep; 30(6):458-66. PubMed ID: 16170675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Monitoring and treatment of dyslipidemia in predialysis patients with chronic renal failure].
    Małecki R
    Pol Arch Med Wewn; 2003 Oct; 110(4):1215-25. PubMed ID: 14699681
    [No Abstract]   [Full Text] [Related]  

  • 51. Dyslipidemia in renal disease patients.
    Blankestijn PJ
    Blood Purif; 1996; 14(1):46-8. PubMed ID: 8718565
    [No Abstract]   [Full Text] [Related]  

  • 52. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.
    Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K
    Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipid disturbances before and after renal transplant.
    Razeghi E; Shafipour M; Ashraf H; Pourmand G
    Exp Clin Transplant; 2011 Aug; 9(4):230-5. PubMed ID: 21819366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of hyperlipidemia in patients on peritoneal dialysis: current approaches.
    Prichard SS
    Kidney Int Suppl; 2006 Nov; (103):S115-7. PubMed ID: 17080100
    [No Abstract]   [Full Text] [Related]  

  • 55. Dyslipidemia treatment guidelines and management systems in Kaiser Permanente.
    Benson VM
    Am J Cardiol; 1997 Oct; 80(8B):85H-88H. PubMed ID: 9373006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dyslipidemia in patients with chronic and end-stage kidney disease.
    Omran J; Al-Dadah A; Dellsperger KC
    Cardiorenal Med; 2013 Oct; 3(3):165-177. PubMed ID: 24454313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dyslipidemia in children and adolescents. Therapeutic bases].
    Forti N; Issa J; Diament J; Giannini SD
    Arq Bras Cardiol; 1998 Dec; 71(6):807-10. PubMed ID: 10347928
    [No Abstract]   [Full Text] [Related]  

  • 58. Two Adults With Hypertriglyceridemia: How should one manage these persons?(#).
    Jayasinghe S
    Malays Fam Physician; 2008; 3(1):34-6. PubMed ID: 25606110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of dyslipidemia in chronic renal failure.
    Toto RD
    Blood Purif; 1996; 14(1):75-82. PubMed ID: 8718569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.